Zobrazeno 1 - 10
of 193
pro vyhledávání: '"M R, Charlton"'
Autor:
Low, Zun Siong1 (AUTHOR), Chua, Damien1 (AUTHOR), Cheng, Hong Sheng1 (AUTHOR), Tee, Rachel1 (AUTHOR), Tan, Wei Ren1 (AUTHOR), Ball, Christopher2 (AUTHOR), Sahib, Norliza Binte Esmail1 (AUTHOR), Ng, Ser Sue1 (AUTHOR), Qu, Jing3 (AUTHOR), Liu, Yingzi4 (AUTHOR), Hong, Haiyu5 (AUTHOR), Cai, Chaonong5 (AUTHOR), Rao, Nandini Chilagondanahalli Lakshmi6 (AUTHOR), Wee, Aileen7 (AUTHOR), Muthiah, Mark Dhinesh8,9,10 (AUTHOR), Bichler, Zoë1 (AUTHOR), Mickelson, Barbara11 (AUTHOR), Kong, Mei Suen1 (AUTHOR), Tay, Vanessa Shiyun1 (AUTHOR), Yan, Zhuang1 (AUTHOR)
Publikováno v:
Advanced Science. 9/18/2024, Vol. 11 Issue 35, p1-19. 19p.
Autor:
D J, Brandhagen, J B, Gross, J J, Poterucha, M R, Charlton, J, Detmer, J, Kolberg, A A, Gossard, K P, Batts, W R, Kim, J J, Germer, R H, Wiesner, D H, Persing
Publikováno v:
American Journal of Gastroenterology. 94:1000-1005
Hepatitis G virus (HGV) is a recently discovered member of the flavivirus family that has been associated with acute and chronic hepatitis. HGV infection has been reported to coexist in 10-20% of patients with chronic hepatitis C. The significance of
Publikováno v:
Diabetes. 46:1336-1340
Autor:
Bai, Yu1, Nan, Yanyang1, Wu, Tao1, Zhu, An1, Xie, Xinlei1, Sun, Yun2, Deng, Yong2, Dou, Zihan1, Hu, Xiaozhi1, Zhou, Rongrui1, Xu, Shuwen1, Zhang, Yuanzhen1, Fan, Jiajun1,3,4 jiajunfan12@fudan.edu.cn, Ju, Dianwen1,3 dianwenju@fudan.edu.cn
Publikováno v:
Advanced Science. 8/21/2024, Vol. 11 Issue 31, p1-12. 12p.
Autor:
M M J, Guichelaar, S, Gawrieh, M, Olivier, K, Viker, A, Krishnan, S, Sanderson, M, Malinchoc, K D, Watt, J M, Swain, M, Sarr, M R, Charlton
Publikováno v:
Obesity (Silver Spring, Md.). 21(9)
Allelic variation (rs738409C→G) in adiponutrin (patatin-like phospholipase domain-containing protein 3, PNPLA3) has been associated with hepatic steatosis and liver fibrosis. The physiologic impact of the PNPLA3 G allele may be exacerbated in patie
Autor:
S K, Asrani, W R, Kim, R A, Pedersen, M R, Charlton, W K, Kremers, T M, Therneau, C B, Rosen, P G, Dean
Publikováno v:
Alimentary pharmacologytherapeutics. 32(6)
The role of interleukin 2 (IL-2) receptor antibodies to avoid the nephrotoxic effects of calcineurin inhibitors in the early post-liver transplant (LT) period is not well defined.To examine the use of daclizumab induction in LT recipients with renal
Autor:
Y, Maor-Kendler, K P, Batts, L J, Burgart, R H, Wiesner, R A, Krom, C B, Rosen, M R, Charlton
Publikováno v:
Transplantation. 70(2)
End-stage liver disease for which no cause can be identified, cryptogenic cirrhosis, is a common indication for liver transplantation. Allograft inflammation and fibrosis have been reported to recur with similar frequencies after liver transplantatio
Autor:
M R, Charlton, D, Brandhagen, R H, Wiesner, J B, Gross, J, Detmer, M, Collins, J, Kolberg, R A, Krom, D H, Persing
Publikováno v:
Transplantation. 65(1)
The significance of hepatitis G (HGV) infection in liver transplant recipients is not known. We set out to determine the pre-orthotopic liver transplantation (OLT) prevalence, the pre- and postoperative viral titers of HGV, and the allograft histolog
Autor:
Ding, Jingjing, Liu, Huaizheng, Zhang, Xiaoxun, Zhao, Nan, Peng, Ying, Shi, Junping, Chen, Jinjun, Chi, Xiaoling, Li, Ling, Zhang, Mengni, Liu, Wen-Yue, Zhang, Liangjun, Ouyang, Jiafeng, Yuan, Qian, Liao, Min, Tan, Ya, Li, Mingqiao, Xu, Ziqian, Tang, Wan, Xie, Chuanming
Publikováno v:
Science Translational Medicine; 11/6/2024, Vol. 16 Issue 772, p1-15, 15p
Publikováno v:
Journal of Materials Chemistry B; 10/28/2024, Vol. 12 Issue 40, p10285-10293, 9p